| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/31/2002 | EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226239A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 07/31/2002 | EP1226235A2 Cell constructs that are suitable for immunotherapy, the production and the use thereof |
| 07/31/2002 | EP1226234A2 Hair transplantation |
| 07/31/2002 | EP1226233A2 Multipotent adult stem cells and methods for isolation |
| 07/31/2002 | EP1226232A2 Synthetic substrate for tissue formation |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226168A1 Ligand activated transcriptional regulator proteins |
| 07/31/2002 | EP1226151A2 Gene expression directed by a super-psa promoter |
| 07/31/2002 | EP1225923A1 Method of inactivating pathogens |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225921A1 TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
| 07/31/2002 | EP1225920A1 Dna-vaccines based on constructs derived from the genomes of human and animal pathogens |
| 07/31/2002 | EP1225909A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 07/31/2002 | EP1225906A1 Mechanically elongated neuronal cells and methods for producing and using these cells |
| 07/31/2002 | EP1225846A2 Bioprosthetic heart valves |
| 07/31/2002 | EP1225814A1 Fibrous-liponutritional complexes and compositions containing them |
| 07/31/2002 | EP1225801A1 Propagation of human hepatocytes in non-human animals |
| 07/31/2002 | EP1035846B1 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
| 07/31/2002 | EP0948338B1 Utilization of an egg-based preparation as an antidepressant |
| 07/31/2002 | EP0886522B1 Use of colostrum for the treatment of constipation |
| 07/31/2002 | EP0719149B1 Anti-fungicidal dermatocosmetic composition |
| 07/31/2002 | EP0700297B1 Surrogate tolerogenesis for the development of tolerance to xenografts |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | EP0683681B1 Injectable implant for correcting wrinkles and skin hollows |
| 07/31/2002 | CN1361825A Novel antifungal agents and fungicides method for the production thereof and their use |
| 07/31/2002 | CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/31/2002 | CN1361695A Analgesic from snake venom |
| 07/31/2002 | CN1360922A Externally applied pain-relieving plaster and its prepn |
| 07/31/2002 | CN1360906A Kidney reinforcing and life essence producing bolus |
| 07/31/2002 | CN1360905A Cancer treating astringent medicine decoction |
| 07/31/2002 | CN1360897A Bee glue purifying technological process |
| 07/31/2002 | CN1360896A Medicine for treating cervical vertebra disease |
| 07/31/2002 | CN1360848A Mixed sodium peroxide solution containing sodium ozonide and its prepn and application |
| 07/31/2002 | CN1360847A Prepn of chlorella extract |
| 07/31/2002 | CN1088377C Traditional Chinese medicine for treating hydroperididymia and funicular hydrocele and preparation process thereof |
| 07/31/2002 | CN1088376C Compound hemostatic |
| 07/31/2002 | CN1088373C Traditional Chinese medicine for treating sexual dysfunction and its prepn. method |
| 07/31/2002 | CN1088371C Hair-blackening and hair-growing capsule |
| 07/31/2002 | CN1088370C Tonguan shugan ointment and preparation process thereof |
| 07/31/2002 | CN1088367C Colour-restoring ointment for treating burn or scald |
| 07/31/2002 | CN1088364C Traditional Chinese medicine composition for treating ischemic encephalopathy and preparation process thereof |
| 07/31/2002 | CN1088363C Medicine for curing children insufficiency of the spleen and anorexia and its preparing method |
| 07/31/2002 | CN1088344C Process for producing selenium or zinc enriched earthworm dry powder or exract |
| 07/31/2002 | CN1088332C Extracting method for animal foremilk |
| 07/30/2002 | US6426361 Method and compositions for increasing the anaerobic working capacity in tissues |
| 07/30/2002 | US6426222 Incubation tissue cells in liquid nutrients |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426210 Storage of materials |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |
| 07/30/2002 | US6426196 Alphavirus structural protein expression cassettes |
| 07/30/2002 | US6426109 Method of treating colostrum |
| 07/30/2002 | US6425769 Genetic engineering |
| 07/30/2002 | US6425414 Fluid management systems |
| 07/30/2002 | CA2236021C Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities: process of making metho ds of using and compositions thereof |
| 07/30/2002 | CA2118686C Gas plasma treated porous medium and method of separation using same |
| 07/30/2002 | CA2104461C Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 07/30/2002 | CA2056619C Method of inactivation of viral and bacterial blood contaminants |
| 07/30/2002 | CA2039230C Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
| 07/25/2002 | WO2002057430A2 Pluripotent adult stem cells derived from regenerative tissue |
| 07/25/2002 | WO2002057429A2 A method for producing a population of homozygous stem cells having a pre-selected immunophenotype and/or genotype |
| 07/25/2002 | WO2002057428A1 Isolation of spore-like cells from tissues exposed to extreme conditions |
| 07/25/2002 | WO2002057424A2 Nucleic acid delivery formulations |
| 07/25/2002 | WO2002057415A2 Method for altering cell fate |
| 07/25/2002 | WO2002057302A2 A virus causing respiratory tract illness in susceptible mammals |
| 07/25/2002 | WO2002056907A2 Molecular antigen array presenting amyloid beta |
| 07/25/2002 | WO2002056905A2 Molecular antigen array |
| 07/25/2002 | WO2002056900A2 Use of slpi for treating chronic inflammatory intestinal diseases |
| 07/25/2002 | WO2002056898A2 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection |
| 07/25/2002 | WO2002056897A2 Pharmaceutical for stimulating the regeneration of tissues |
| 07/25/2002 | WO2002056865A2 Peat product composition, method for the production and use thereof |
| 07/25/2002 | WO2002056830A2 The use of immature dendritic cells to silence antigen specific cd8+t cell function |
| 07/25/2002 | WO2002056804A2 Presbyopia treatment by lens alteration |
| 07/25/2002 | WO2002044346A3 Stem cells, method for expansion in vitro and use thereof |
| 07/25/2002 | WO2002038103A3 Probiotic compositions and methods against bacterial infection in livestock animals |
| 07/25/2002 | WO2002035992A3 Tissue-engineered vascular structures |
| 07/25/2002 | WO2002030256A3 Diagnostic indicator of thymic function |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2001097872B1 Bioadhesive compositions and methods of preparation and use |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001057208A3 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 07/25/2002 | WO2001011011A9 Multipotent adult stem cells and methods for isolation |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | US20020100065 Generating human organs of preferential classification; obtain fetus, graft stem cells into fetal environment, recover hybrid organ, recover organ |
| 07/25/2002 | US20020099448 Multi-formed collagenous biomaterial medical device |
| 07/25/2002 | US20020099174 Filtration of plasma mixtures using cellulose-based filter aids |
| 07/25/2002 | US20020099033 Method and composition for treating sleep apnea |
| 07/25/2002 | US20020099029 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 07/25/2002 | US20020099024 Including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell. |
| 07/25/2002 | US20020099012 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020099006 Herpes viruses for immune modulation |
| 07/25/2002 | US20020098587 Dendritic cells; methods |
| 07/25/2002 | US20020098585 Hypoxia-mediated neurogenesis |
| 07/25/2002 | US20020098582 Differentiated stem cells suitable for human therapy |
| 07/25/2002 | US20020098559 Treating isolated pancreatic islet cells; obtain pancreatic cells, culture, cover cell in membrane, monitor cells |